DUBLIN, May 11, 2021 /PRNewswire/ -- The "IVD Procedure Volumes 2020-2025" report has been added to ResearchAndMarkets.com's offering. In vitro diagnostic (IVD) test volumes are the gold standard for ...

DUBLIN--(BUSINESS WIRE)--The "Physician Office In Vitro Diagnostic (IVD) Test Markets" report has been added to ResearchAndMarkets.com's offering. This report analyzes trends in global demand for in ...

In vitro diagnostics (IVDs) are a mainstay of modern medicine. People of all ages and their healthcare providers rely on these tests to determine the risk of a wide range of chronic and acute diseases ...

Company also has a lung cancer test in development. Epigenomics confirmed the European launch of Epi proColon, reportedly the first CE-marked IVD blood test for detecting colorectal cancer. The ...

The confusing aspect when new technologies begin to impact an industry is that these technologies do not appear to be new to the researchers or those closely monitoring the sector. It is the ...

Quest Diagnostics will soon begin offering a new blood-based in-vitro diagnostic test for Alzheimer’s. The disease affects nearly 7 million Americans. The Lumipulse G pTau 217/β-Amyloid 1-42 Plasma ...

The Food and Drug Administration (FDA) published its long-awaited Final Rule that will regulate laboratory developed tests (LDTs) as in vitro diagnostic (IVD) medical devices. FDA published a ...

COVID-19 created unprecedented demand for in vitro diagnostic expertise and products, and Kalorama Information's latest market research report provides a guide to the past, present, and future of the ...

Labcorp Holdings, Inc. LH has announced the nationwide availability of the Lumipulse pTau-217/Beta Amyloid 42 Ratio — the first FDA-cleared blood-based in-vitro diagnostic (IVD) test to assist in ...

The IVD market in China is likely to grow at a rapid pace during the forecast period. The increased incidences of the infectious and chronic diseases are one of the major drivers. The leading factors ...